Skip to main navigation About Us Medicines & Focus Research & Development Responsibility Investors News & Events Careers Corporate Governance Board Committee Charters Audit and Risk Committee Charter Compensation Committee Charter Financial Operating Committee Charter Nominating and Corporate Governance Committee Charter Compliance Programs Compliance Program Governance Documents Corporate Governance Guidelines Clawback Policy Insider Trading Policy Code of Business Conduct and Ethics Audit and Non-Audit Services Pre-Approval Policy Lead Independent Director Share Ownership and Holding Guidelines Procedures for Reporting Financial and Compliance Matters; No Retaliation Policy (“Whistleblower Policy”) Committee Composition Below is a summary of our Board committee structure and membership information. Chairperson Director Financial Expert Board Audit and Risk Compensation Financial Operating Nominating and Corporate Governance Emily Peterson Alva * David W. Anstice * Shane M. Cooke * David A. Daglio * Wendy L. Dixon, Ph.D. * Richard B. Gaynor, M.D. * Cato T. Laurencin, M.D., Ph.D. * Brian P. McKeon * Richard F. Pops Nancy L. Snyderman, M.D. * Andy Wilson * Nancy J. Wysenski * * denotes independent director + denotes lead independent director Investor Tools Print Page Contact Us RSS Email Alerts Contact Us Terms of Use Privacy Policy Sitemap ©2021 Alkermes. All Rights Reserved.